Wedbush maintained Biogen (NASDAQ:BIIB) $263 price target
Wedbush analyst Laura Chico reiterates Biogen (NASDAQ:BIIB) with a Neutral and maintains $263 price target.
Wedbush maintained Biogen (NASDAQ:BIIB) $263 price target Read Post »
Biogen
Needham Reiterates Buy on Biogen (NASDAQ:BIIB) , Maintains $325 Price Target
Needham analyst Ami Fadia reiterates Biogen (NASDAQ:BIIB) with a Buy and maintains $325 price target.
Needham Reiterates Buy on Biogen (NASDAQ:BIIB) , Maintains $325 Price Target Read Post »
Biogen (NASDAQ:BIIB) expects 2023 earnings of $15-16 per share versus $15.87
Biogen (NASDAQ:BIIB) expects 2023 earnings of $15-16 per share versus $15.87。
Biogen (NASDAQ:BIIB) expects 2023 earnings of $15-16 per share versus $15.87 Read Post »